In addition, since new generation of AChE inhibitors targeting in Alzheimer’s-associated memory impairment are currently being inspected in human clinical trials [39], we examined whether ZN/VB compounds may reduce AChE activity (Figure 4C). This evidence concerns the gene ACHE and memory impairment.